| | SLO | ENG | Cookies and privacy

Bigger font | Smaller font

Show document

Title:Farmakogenomika v zdravljenju astme
Authors:Berce, Vojko (Author)
Potočnik, Uroš (Author)
Files:URL http://www.sfd.si/modules/catalog/products/prodfile/fv_6_2008_prelom.pdf
 
Language:Slovenian
Work type:Unknown ()
Typology:1.02 - Review Article
Organization:MF - Faculty of Medicine
Abstract:Med posamezniki obstajajo velike razlike v učinku protiastmatične terapije, ki so pogojene predvsem z različnim genetskim zapisom. Namen farmakogenomike je poiskati tiste polimorfizme, ki so povezani z vsemi učinki določenega zdravila. Farmakogenomika pri astmi zaenkrat proučuje predvsem vpliv genov, ki kodirajo receptorje za zdravila, komponente postreceptorske signalne transdukcije in transkripcijske dejavnike. Največ raziskav je bilo narejenih na področju farmakogenomike beta2 agonistov. Mutacija Arg/Arg na mestu 16 gena ADRB2, ter mutacije v genih LTC4S, ALOX5 in CRHR1 spremenijo odziv na protiastmatično terapijo. Cilj farmakogenomike astme pa je poiskati čimbolj učinkovito protiastmatično zdravilo z čimmanj stranskimi učinki individualno za vsakega posameznika na podlagi njegovega genotipa.
Keywords:farmakogenomika, astma, polimorfizmi
Year of publishing:2008
UDC:575.111:616.248
ISSN on article:0014-8229
COBISS_ID:12895766 Link is opened in a new window
NUK URN:URN:SI:UM:DK:SUATGBG4
Views:1718
Downloads:65
Metadata:XML RDF-CHPDL DC-XML DC-RDF
Categories:Misc.
:
  
Average score:(0 votes)
Your score:Voting is allowed only for logged in users.
Share:AddThis
AddThis uses cookies that require your consent. Edit consent...

Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Record is a part of a journal

Title:Farmacevtski vestnik
Shortened title:Farm. vestn.
Publisher:Slovensko farmacevtsko društvo
ISSN:0014-8229
COBISS.SI-ID:3105794 New window

Secondary language

Language:English
Title:Pharmacogenomics in asthma treatment
Abstract:There are substantial differences in the effect of antiasthmatic therapy between individuals which are dependent on the diversity of the genetic code. The purpose of pharmacogenomics is to find out those polymorphisms, which are connected with all effects of certain drug. For now the pharmacogenomics of asthma above all study the influence of the genes which code for drug receptors, signal transduction components and transcription factors. Most studies were done in the field of pharmacogenomics of beta2 agonists. Gene mutations that are known to alter the response to asthma therapy include Arg/Arg at position 16 in ADRB2 gene, mutations of LTC4S and ALOX5 and CRHR1 variants. The goal of pharmacogenomics is to find out most efficient drug without adverse side effects individually suited for each patient on basis of his genotype.
Keywords:pharmacogenomics, asthma, polymorphisms


Comments

Leave comment

You have to log in to leave a comment.

Comments (0)
0 - 0 / 0
 
There are no comments!

Back
Logos of partners University of Maribor University of Ljubljana University of Primorska University of Nova Gorica